Safety and immunogenicity of the group B streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial by Majela Gonzalez-Miro, Andrzej Pawlowski, Janne Lehtonen, Duojia Cao, Sara Larsson, Michael Darsley, Geoff Kitson, Per B. Fischer, Bengt Johansson-Lindbom

Get full text